For several years, nutrient profiling has been discussed as a regulatory instrument for health claims made on foods. The aims of the European Commission are mainly to protect consumers from misleading and even dangerous information and to ban advertisements for foods and menus for children if they are not healthy. Generally, nutrient profiling will be established on the basis of contents of different nutrients and substances like fat, saturated fat, trans fatty acids, salt/sodium and sugars ‘whose excessive intakes in the overall diet are not recommended and those such as poly- and monounsaturated fats, available carbohydrates other than sugars, vitamins, minerals, protein and fiber’. In the present paper, 4 out of >20 proposals will be discussed: the US requirement for health claims (FDA Code), the ‘a little a lot’ system from the UK, the ‘tripartite classification’ model of the Netherlands and the FSA scoring system from the UK. At present, several details remain uncertain, e.g. the reference basis (100 g, serving size or 100 kcal, respectively), moreover the use of thresholds or a scoring system. The evaluation may be ‘across the board’ versus in categories, respectively. In all cases, exceptions will be necessary.

Keywords:
Health claims, Thresholds, Scoring system, Evaluation ‘across the board’, Food categories, Consumer protection, Disqualifying nutrients
This content is only available via PDF.
© 2007 S. Karger AG, Basel
2007
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.